Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 342,735 | 390,363 | 134,205 | 90,816 | 132,973 |
| Cost of Goods | 67,898 | 15,146 | 7,091 | 6,039 | 5,544 |
| Gross Profit | 274,837 | 375,217 | 127,114 | 84,777 | 127,429 |
| Operating Expenses | 326,135 | 138,549 | 117,888 | 115,169 | 57,275 |
| Operating Income | -50,400 | 236,814 | 9,317 | -30,353 | 70,698 |
| Interest Expense | 73,436 | 9,275 | 911 | 39 | 133 |
| Other Income | 599 | -14,431 | -3,826 | 520 | 557 |
| Pre-tax Income | -123,237 | 213,108 | 4,580 | -29,872 | 71,122 |
| Income Tax | -47,499 | 81,346 | -38,733 | -91 | 396 |
| Net Income Continuous | -75,738 | 131,762 | 43,313 | -29,781 | 70,726 |
| Net Income | $-75,738 | $131,762 | $43,313 | $-29,781 | $70,726 |
| EPS Basic Total Ops | -75.56 | 135.53 | 45.58 | -31.78 | 77.96 |
| EPS Basic Continuous Ops | -75.55 | 135.55 | 45.78 | -31.95 | 77.73 |
| EPS Diluted Total Ops | -75.56 | 122.94 | 44.98 | -31.78 | 75.56 |
| EPS Diluted Continuous Ops | -75.55 | 119.17 | 45.14 | -31.95 | 75.62 |
| EBITDA(a) | $50,966 | $253,039 | $16,261 | $-27,461 | $71,118 |